Decreased m6A level by knockdown of the expression of METTL3 and/or METTL14 or overexpression of the eraser FTO can significantly accelerate tumorigenesis, specifically promoting the growth of human GSCs, as well as their self-renewal and tumor progression. The gene discussed is METTL3; the disease is neoplasm.